(lp0
S"Here's Why BioCryst Pharmaceuticals Inc. Catapulted Higher by as Much as 17% Motley Fool - Feb 28, 2017 Shares of BioCryst Pharmaceuticals , a biopharmaceutical company primarily focused on the development of small-molecule drugs that block enzymes associated with the development of diseases, catapulted higher by as much as 17%&nbsp;...BioCryst Pharmaceuticals, Inc. : A Discount Entry? - Market ExclusiveBioCryst Reports Fourth Quarter and Full Year 2016 Financial Results - GlobeNewswire "
p1
aS"The Reason Behind BioCryst Pharmaceuticals, Inc.'s 12% Pop Higher Motley Fool - Mar 8, 2017 Shares of BioCryst Pharmaceuticals , a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu&nbsp;...BioCryst Pharmaceuticals Prices Public Offering of Common Stock - GlobeNewswire BioCryst Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 10 - Equities.com"
p2
aS'BioCryst Pharmaceuticals, Inc.  Files An 8-K Regulation FD Disclosure Market Exclusive - Apr 12, 2017 BioCryst Pharmaceuticals, Inc.  is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases.'
p3
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 20 ... Equities.com - Mar 20, 2017 Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.21. Shares closed at $9.20 after opening at $8.82 for a move of 3.95%.'
p4
aS'Traders Take Note: BioCryst Pharmaceuticals Inc  Stock Drops ... CML News - 21 hours ago Take Note: BioCryst Pharmaceuticals Inc  has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and&nbsp;...'
p5
aS'BioCryst Pharmaceuticals Inc.  Plunges 5.68% on April 12 Equities.com - Apr 12, 2017 BioCryst Pharmaceuticals Inc.  had a rough trading day for Wednesday April 12 as shares tumbled 5.68%, or a loss of $-0.41 per share, to close at $6.81.Lookout for this Stock: BioCryst Pharmaceuticals, Inc.  - StandardOracleBioCryst Pharmaceuticals, Inc.  Stake Raised by Fmr LLC - BNB Daily '
p6
aS'BioCryst Pharmaceuticals, Inc.  Makes The Move To Publicize Its ... Journal Transcript - Mar 13, 2017 BioCryst Pharmaceuticals, Inc.  which happens to be a leading pharmaceutical company whose activities centre around commercialization as well as development of top-notch treatments to deal with rare and infectious diseases has today&nbsp;...BioCryst Pharmaceuticals, Inc.  Files An 8-K Entry into a ... - Market ExclusiveActive Volume Stock: BioCryst Pharmaceuticals, Inc.  - HugoPress'
p7
aS'Stock Returns: BioCryst Pharmaceuticals Inc  is Beating Applied ... CML News - Apr 17, 2017 This is a snapshot to compare the stock returns for Applied Genetic Technologies Corporation  versus BioCryst Pharmaceuticals Inc  . The stock return points we compare look at the last three-months, six-months and&nbsp;...'
p8
aS"BioCryst Pharmaceuticals Inc.  Plunges 9.41% on April 05 Equities.com - Apr 5, 2017 BioCryst Pharmaceuticals Inc.  had a rough trading day for Wednesday April 05 as shares tumbled 9.41%, or a loss of $-0.78 per share, to close at $7.51.Analyst's Predictions on BioCryst Pharmaceuticals, Inc. , Fifth Street ... - StockNewsJournalFranklin Street Advisors Inc. NC Has $412000 Stake in BioCryst Pharmaceuticals ... - The Cerbat Gem"
p9
aS'BioCryst Pharmaceuticals Inc.  Plunges 9.89% on March 21 Equities.com - Mar 21, 2017 BioCryst Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 9.89%, or a loss of $-0.91 per share, to close at $8.29.'
p10
a.